Drug Development Process | Drug Approval

Track and understand the impacts of market events for the companies, diseases, products, and targets you care about. Leverage reliable real-time data, analyst insights, and proprietary likelihood of approval analytics to predict and successfully navigate what lies ahead.

How it helps
Biomedtracker's exclusive likelihood of approval analyses highlight the "bottom line" impact of today’s news on your business. Our expert industry analysts draw insights from closely monitoring companies, clinical trials, deals, and regulatory meetings to capture and report on the most critical events.

How it works
Our data and analysts insights cut through the noise, so you not only know what happens, but understand why it matters for your business. Biomedtracker provides analysis of commercial, clinical, and regulatory activities as they happen, and present them to you via an easily searchable interface and automated alerts that keeps you at the top of your game.

Request a demo

Biomedtracker, Datamonitor Healthcare

Plan for 2021 ASCO with Pharma Intelligence

The Pharma Intelligence analyst team will be covering the 2021 ASCO virtual meeting from June 4-8, 2021.

Biomedtracker

2020 Deal-Making Roundup

Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

Citeline, Biomedtracker, Pharma Consulting, Datamonitor Heal...

COVID-19 24 hour webinar recordings

Catch up on any missed COVID-19 24 hour webinar sessions

Biomedtracker

Biopharma Partnering and Financing Trends, H1 2020 Whitepaper

Get an inside view into the trends powering COVID-era deal making in the life sciences with your free copy of “Biopharma Partnering and Financing Trends, H1 2020”. Informa Pharma Intelligence takes you inside the forces shaping the industry

Biomedtracker, Scrip

39th Annual J.P. Morgan Healthcare Conference 2021

Keep up with events as they unfold at the 39th Annual J.P. Morgan Annual Healthcare Conference on January 11-14, 2021. Pharma Intelligence and Insights journalists will bring you real time reporting, highlighting important events and key takeaways from every day of the largest and most informative healthcare investment symposium in the industry.

Biomedtracker

2021 Clinical Development Success Rates

This is both an updated study of clinical drug development success rates from our 2016 report, and an expansion into the drivers of success with the addition of machine learning modeling to analyze the predictive factors contributing to drug development.

Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet...

COVID-19 Infographic

Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.

Datamonitor Healthcare, Biomedtracker

COVID-19 and the impact on the clinical trial space

The effect of COVID-19 on clinical trials, the industry response, and the return to full operations

Biomedtracker

A Historic Decade of Deal Making

In preparation for the webinar, download your free infographic, a snapshot view of M&A’s biggest deals and major players and what their activities indicate for the year ahead.

Biomedtracker

A Decade of Biopharma Mergers and Acquisitions and Outlook for 2020 Whitepaper

Using M&A activity as a barometer for the overall health of the biopharma industry, we explore biopharma’s biggest deals of the past decade and examine what they may presage for the year to come. Dive into key insights on trends, M&A drivers, companies to watch, and more.

Biomedtracker, Meddevicetracker

Q4 Outlook Report 2020

The world-class data contained in this report extract will keep you up to speed on the drug development landscape for better decision-making

Biomedtracker, Datamonitor Healthcare

Key Potential Drug Launches in 2021

Valuable insight and expert analyst commentary 2021’s expected drug launches, their indications, commercial potential, regulatory catalysts and more.

Pharmaprojects, Biomedtracker

The Race to Find a COVID-19 Treatment - Infographic

Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.

Biomedtracker

Biomedtracker Potential Pivots in 2020

In this infographic, we provide insight into key trials that are expecting developments in the approval process.

Biomedtracker, Datamonitor Healthcare

2020 Early Outlook Webinar

Anticipate the biggest, most impactful expected catalysts of early 2020 with the guidance and insights from Pharma Intelligence. Building off Biomedtracker’s Early 2020 Outlook report, our live webinar will include market context for these upcoming milestones and additional insights from Datamonitor Healthcare’s Therapeutic Area Directors.

Biomedtracker: see the drug development process through analysts’ eyes

Real-time tracking and analysis of the drug development pipeline

What's included

Below are the Feature List

Market Events & Catalysts

Likelihood of Approval

Deals Coverage

AdComm Insight

Comprehensive Reports

Ask-the-Analyst™

Pharma Intelligence: latest

Meet the team

Below are the Analyst Profile

Gail Parziale

Management, ​Head of Intelligence Editorial Operations

Rachel Meighan-Mantha

Analyst, Principal Analyst

David Dahan

Analyst, Scientific Analyst

Related Products

Datamonitor Healthcare: data analysis and insight

Pink Sheet

Trialtrove: gold standard clinical trials intelligence

Next steps

This is Contactus Section

Request a Demo

How can we help you?

Pharma Report Store

Management, Head of Intelligence Editorial Operations